SEMICONDUCTOR ANALYTICS

Women Have Reduced Response to Ankylosing Spondylitis Treatments, Study Finds - Ankylosing Spondylitis News

 
 
Ankylosing Spondylitis NewsWomen Have Reduced Response to Ankylosing Spondylitis Treatments, Study FindsAnkylosing Spondylitis NewsAll patients had received TNF inhibitors (TNFi), which are anti-tumor necrosis factor (TNF) treatments that target the TNF protein, responsible for inflammation in many diseases, including ankylosing spondylitis. After a year of treatment, researchers ...
 
Related NewsFeeds

Wall Street JournalFive Drug Startups Reveal Plans to Join Biotech IPO BlitzWall Street JournalFive heavily funded biotech startups could soon join the parade of drugmakers marching onto the public ma

0 visits

GeekWireBiotech company Omeros and former exec battling in court over non-compete deal and bonusesGeekWireOmeros, one of Seattle's biggest biotech companies, is in the midst of a contentious legal

0 visits

MedPage TodayEnthesitis in PsA: A New Focus of Treatment?MedPage Today... (SPARCC) index was achieved by 73.9% of patients receiving the IL-12/23 blocker ustekinumab (Stelara) by week 24 compared with

0 visits

Everyday Health, Inc. (blog)A Diabetes Diagnosis After Age 50 May Be an Early Sign of Pancreatic Cancer in Black, Latino PeopleEveryday Health, Inc. (blog)June 22, 2018. A type 2 diabetes diagnosis af

0 visits

WWBT NBC12 NewsHow to delay the onset and risk of diabetes - NBC12 - WWBT - Richmond, VA News On Your SideWWBT NBC12 NewsThe National Diabetes Prevention Program (NDPP) is a proven and effective way t

0 visits

WWBT NBC12 NewsHow to delay the onset and risk of diabetesWWBT NBC12 NewsCosts associated with diabetes care for Medicare beneficiaries was estimated at $42 billion more for persons with diabetes than

0 visits

Trends and Challenges in Fibromyalgia Drug ResearchPharmaLive (press release)It's hard to fault fibromyalgia patients for feeling ignored and underserved. For years, many health professionals doub

0 visits

Platform Powered by AI Named Winner in Diabetes Innovation ChallengePharmacy TimesThe Cuinary Coach, a Whisk platform powered by artificial intelligence (AI), has been awarded the top prize in the Asc

0 visits

KIRO SeattleMan with diabetes and schizophrenia reported missing in Auburn. Have you seen him?KIRO SeattleAUBURN, Wash. - A schizophrenic diabetic is missing in Auburn and police are asking the public

0 visits

NewsweekType 1 Diabetes: Tuberculosis Vaccine Could Offer "Major Advancement? in TreatmentNewsweekEvery day, thousands of Americans prick their fingers and stab their legs, bellies and buttocks four,

0 visits

Immune Pharmaceuticals And Bertilimumab: A Work In ProgressSeeking AlphaImmune Pharmaceuticals (NASDAQ:IMNP) is a clinical stage biopharmaceutical company focused on the development and commercializat

0 visits

StockNewsGazetteInfinity Pharmaceuticals: Cheap With A Key Data Readout ComingSeeking AlphaOn the ROTY Winners/Losers page where I try to help members learn from my mistakes and successes alike, Infin

0 visits

The Lincolnian OnlineArrowhead Pharmaceuticals - Pullbacks Are Becoming Rare, So Take Advantage If You Love The PotentialSeeking AlphaArrowhead Pharmaceuticals (ARWR) has had a terrific run this last

0 visits

HealthNewsReview.orgClinical Challenges: Managing Older Patients With Diabetes ...MedPage TodayOlder patients with diabetes can pose a challenge for providers to manage, as their unique goals and risk

0 visits

New York TimesDiabetes Patients at Risk From Rising Insulin PricesNew York TimesA surprisingly large number of people with diabetes are using less insulin than prescribed because of the rising cost of

0 visits

Motley Fool2 Biotech Stocks That Tanked This Week: Can They Recover?Motley FoolIf you're looking for biotech stock bargains, the scrap heap isn't a bad place to start. Hardly a day goes by wit

0 visits

Orig3n Founders Named Finalists for Ernest and Young Entrepreneur Of The YearAE 2018 AwardPR Newswire (press release)BOSTON, June 22, 2018 /PRNewswire/ -- Orig3n, a Boston-based biotech company pionee

15 visits

Motley FoolBig News Sends Tandem Diabetes Soaring 10.2% TodayMotley FoolFor this reason, the approval of Tandem Diabetes Care's latest upgrade to its insulin pumps is important. In trials, using T

0 visits

Motley FoolBig News Sends Tandem Diabetes Soaring 10.2% Today -- The ...Motley FoolThe FDA has given the OK to the company's automated insulin system.Big News Sends Tandem Diabetes Soaring 10.2% T

0 visits

Smarter AnalystFDA Approves World's First Long-Term Implantable Continuous Glucose Monitoring SystemPharmaLive (press release)Written by: PR Newswire | mediasite@prnewswire.com | Dated: Thursday,

0 visits